HPLC Method for Heparin on BIST A by SIELC Technologies

High Performance Liquid Chromatography (HPLC) Method for Analysis of Heparin.

Heparin, also known as unfractionated heparin and UFH, is a WHO-recognized essential medicine with the chemical formula C₂₆H₄₂N₂O₃₇S₅.  It is known for its anticoagulant properties and used to treat heart attacks, angina, deep-vein thrombosis, and more. It works through inhibiting thrombin, which prevents new blood clots from forming, but does not break down existing ones. You can find detailed UV spectra of Heparin and information about its various lambda maxima by visiting the following link.

Due to its very polar and polymeric nature, separating and quantifying Heparin using traditional HPLC methods can be quite difficult. Using SIELC’s newly introduced BIST™ method, however, Heparin and its salts can be separated easily on a negatively-charged, cation-exchange BIST A column. There are two keys to this retention method: 1) a multi-charged, positive buffer, such as N,N’-Dimethylpiperazine (DMP), which acts as a bridge, linking the negatively-charged anion analytes to the negatively-charged column surface and 2) a mobile phase consisting mostly of organic solvent (such as MeCN) to minimize the formation of a solvation layer around the charged analytes. Other positively-charged buffers that can generate BIST™ include TMDAP, Calcium acetate, and Magnesium acetate. Using this new and unique analysis method, Heparin and its salts can be separated and retained with high selectivity and great peak shape. This method can be detected and is compatible with ELSD, CAD, and Mass Spectrometry (LC-MS).